A Study to Assess the Safety and Tolerability of Single Doses of AZD4076 in Healthy Male Subjects

Summary

This is a first-in-human (FIH) study designed to evaluate the safety, tolerability, and pharmacokinetics (PK) of AZD4076 tetracosasodium in healthy male subjects at increasing single doses

Timeline

Start

2015-11-24

Primary completion

2017-11-04

Completion

2025-10-27

Drugs

Indications